Cell Discovery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2022-06-04 dgdgdgygygyg

审稿速度:2.0 | 投稿命中率:5.0
经验分享：即时影响因子，35.511分。

130 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2022-05-19 ms3000001535242575

有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少

100 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2022-03-12 ms8000000043577878

投稿14天，才收到通知没有外审。不是很快啊。

1 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2022-04-25 dgdgdgygygyg

审稿速度:2.0 | 投稿命中率:5.0
经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。

109 0

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2022-04-25 dgdgdgygygyg

审稿速度:2.0 | 投稿命中率:25.0
经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。

150 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2021-04-29 ms5000002143658131

作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多

157 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2022-04-06 ms8761278874018489

审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的

79 0

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2021-12-29 rayms

同一杂志社不同期刊如何转投（transfer）？

83 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

所有作者在文章接收之后都会接收到邮件吗？

79 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224487, encodeId=dcc9122448e2d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：即时影响因子，35.511分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jun 04 23:07:17 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220817, encodeId=cf97122081ed3, content=有没有大佬分享下他的完整流程，从一开始到最后每一步是显示什么状态，每个状态大概多长时间？这种审稿流程不明，时间拖太长，折磨人啊，不行就撤稿了，好杂志也不少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80b38125070, createdName=ms3000001535242575, createdTime=Thu May 19 00:17:33 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214336, encodeId=115d1214336bd, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：不太明白，对于国产杂志而言，这个杂志的文章质量和作者质量都要比STTT高上一截，为啥还有黑的，很明显cell research和cell discovery会是国产期刊的top 2。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 22:40:01 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214036, encodeId=cb95121403633, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：今年6月IF即将突破35分，现在已经非常难投了。cr已经起势自不必说，cd现在的作者质量也极高，院士杰青优青作通讯的文章甚至占了1/3以上。趋势很明显，两个杂志主编都是李，他要把中科院旗下双子星cell research和cell discovery打造成国内第一和第二的国产杂志。质量上会明显超过sttt，prorein cell之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 08:17:55 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208987, encodeId=2081120898e57, content=审稿两个月左右返回修稿意见，现在已经修回20天了，请问各位修稿后多久有答复的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GkCliaSYcWvKeicPsQYhiaf8av7zv9nL58YD5I19X3PT9iaH9u4VewtibxCJ2xuIGe01d4eKXUXNgQNhxgFo7uPBM3w/132, createdBy=bbd85078070, createdName=ms8761278874018489, createdTime=Wed Apr 06 14:51:45 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107472, encodeId=ff13110e47249, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107471, encodeId=3420110e47156, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=)]

2021-03-23 zyn930812

最近有人投稿吗？under consideration 9天了……音信全无

116 9

展开9条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务